Literature DB >> 1312033

Inhibitory effect of oryzacystatins and a truncation mutant on the replication of poliovirus in infected Vero cells.

H Kondo1, S Ijiri, K Abe, H Maeda, S Arai.   

Abstract

Poliovirus, a picornavirus family member, requires the processing of its poly-protein by its own cysteine proteinase for replication. Oryzacystatin-I and oryzacystatin-II, proteinaceous cysteine proteinase inhibitors (cystatins) of rice seed origin, were found to inhibit the replication of poliovirus effectively in infected Vero cells in vitro. Truncated oryzacystatin-I, which lacks the NH2-terminal 25 amino acid residues of the intact protein, is an even more effective inhibitor, eliciting its effect at concentrations of less than 0.25 nmol/ml. The low molecular weight cysteine proteinase inhibitors, E-64, E-64C and loxistatin, showed no anti-viral effect at any concentration investigated.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1312033     DOI: 10.1016/0014-5793(92)80097-z

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  4 in total

1.  Decreased metastatic spread in mice homozygous for a null allele of the cystatin C protease inhibitor gene.

Authors:  C G Huh; K Håkansson; C M Nathanson; U P Thorgeirsson; N Jonsson; A Grubb; M Abrahamson; S Karlsson
Journal:  Mol Pathol       Date:  1999-12

2.  Expression of a cysteine proteinase inhibitor (oryzacystatin-I) in transgenic tobacco plants.

Authors:  S A Masoud; L B Johnson; F F White; G R Reeck
Journal:  Plant Mol Biol       Date:  1993-02       Impact factor: 4.076

3.  Antiviral effect of oryzacystatin, a proteinase inhibitor in rice, against herpes simplex virus type 1 in vitro and in vivo.

Authors:  H Aoki; T Akaike; K Abe; M Kuroda; S Arai; R Okamura; A Negi; H Maeda
Journal:  Antimicrob Agents Chemother       Date:  1995-04       Impact factor: 5.191

4.  Transfection of COS cells with human cystatin cDNA and its effect on HSV-1 replication.

Authors:  T R Weaver-Hiltke; L A Bobek
Journal:  Ann N Y Acad Sci       Date:  1998-04-15       Impact factor: 5.691

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.